Skip to content
  • Home
  • Subscribe to email list

Pharminent

  • Home
  • Subscribe to email list
Cancer, Immunotherapy July 7, 2017July 22, 2017

Celgene joins PD-1 race via partnership with BeiGene

The pharma giant will pay the Chinese firm up to $980m in milestone payments http://www.pmlive.com/pharma_news/celgene_joins_pd-1_race_via_partnership_with_beigene_1197746

Post navigation

← Previous Post

Novartis’ psoriasis drug gets label boost

Next Post →

Alnylam Buckles Down On A Belt Of Rare Diseases

Categories
RSS Emerging Markets
  • 5 Secrets For Breaking Into India’s Booming Market August 18, 2018
  • Takeda Eyes China Drug Market as its Next Big Opportunity Following Shire Deal July 19, 2018
  • HealthifyMe crosses 5 mn registered users to establish its position in India’s digital health & fitness space July 6, 2018
  • WuXi Biologics to build U.S. plant as it rapidly moves beyond its China base June 11, 2018
  • GE grows FlexFactory presence in China with another cell therapy plant deal June 8, 2018
  • Chinese R&D sector takes ‘significant step’ as outsourcing demand increases December 7, 2017
  • Six factors shaping healthcare in emerging markets October 10, 2017
RSS Biosimilar
  • Mylan becomes latest to strike licensing deal with AbbVie for Humira biosimilar July 17, 2018
  • Expert Predicts the Trajectory of Biosimilars in Oncology June 8, 2018
  • Novartis’ Sandoz scores EU approval for Remicade biosimilar May 24, 2018
  • AbbVie, Samsung Bioepis in deal; Humira biosimilar U.S. release in 2023 April 5, 2018
  • Mundipharma inks third biosimilar deal with Celltrion March 21, 2018
  • Industry touts savings potential of generics and biosimilars February 14, 2018
  • Biogen looking to up its stake in Samsung biosimilar JV February 1, 2018
RSS Pricing
  • Drug maker Novo Nordisk expects lower U.S. prices next year August 8, 2018
  • Novartis follows Pfizer’s lead, pledges no price hikes in 2018 July 18, 2018
  • CMS quietly cancels plan for indication-based pricing on Novartis’ Kymriah July 10, 2018
  • Sanofi tweaks pricing policies, discloses 8.4% net price decline in 2017 June 1, 2018
  • Hospitals To Be Required To Post Prices Online As Part Of CMS Push To Increase Transparency April 25, 2018
  • Pricing and Market Access Outlook 2018 March 5, 2018
  • Roche hemophilia drug lowers costs despite high price: ICER January 27, 2018
RSS Payer
  • CVS adopts ICER metrics in shift to value-based drug pricing August 15, 2018
  • CMS to allow step therapy in Medicare Advantage plans August 8, 2018
  • Payers, doctors weigh AI’s disruptive prescribing potential July 23, 2018
  • CMS Wants To Experiment With Alternative Pay Model For Medicare Advantage Plans July 3, 2018
  • FDA permits more expansive communication between drugmakers, payers June 13, 2018
RSS Marketing
  • AstraZeneca at Cannes: Healthcare delivery’s speeding away from pharma’s marketing model June 26, 2017
  • What marketers need to know about tax reform, off-label promotion, pricing May 17, 2017
  • The Impact of AI and Machine Learning in Marketing February 27, 2017
RSS R&D
  • Virtual Reality: A Potential New Tool in Healthcare and Therapy R&D July 9, 2018
  • Pharma R&D Investments Moderating — But Still High June 12, 2018
  • Creating a connected ecosystem to gain insights across R&D May 15, 2018
RSS Company News
  • Regeneron takes $100m stake in bluebird, with ‘long-view’ on drug discovery August 7, 2018
  • Pfizer’s Read Predicts the End of Drug Rebates August 1, 2018
  • Novo Nordisk is Using Real-World Data from Digital Health Portfolio to Help Patients July 27, 2018
  • Novartis Taps Shyft Analytics To Drive Company’s Digital Transformation July 26, 2018
  • Novartis to spin off eye unit Alcon June 29, 2018
  • Roche to buy rest of genetics firm Foundation Medicine June 20, 2018
  • Sanofi partners with Translate Bio on mRNA vaccines June 11, 2018
RSS Immunotherapy
  • Novartis and Gilead rival CAR-Ts approved in Europe, but supply capacity in question August 28, 2018
  • State of Immunotherapy Continues to Shift in NSCLC July 13, 2018
  • Merck impresses NICE with Keytruda data—and discounts—cueing up a CDF switch June 8, 2018
  • Merck, Foundation Medicine to Develop Companion Diagnostics for Immunotherapy May 24, 2018
  • Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens May 2, 2018
  • MSD’s Keytruda bags another trial success in NSCLC April 10, 2018
  • FDA Expands Bristol-Myers Squibb’s Opdivo Dosing Schedule March 6, 2018
RSS Cardiovascular
  • BMS, Pfizer’s fast-growing Eliquis is about to steamroll market-leader warfarin: exec July 30, 2018
  • Esperion talks cholesterol drug pricing after third positive study May 23, 2018
  • Regeneron/Sanofi to cut price of heart drug in Express Scripts deal May 1, 2018
  • Amgen gets prevention claim for cholesterol drug Repatha December 4, 2017
  • AstraZeneca outlicenses Brilinta reversal agent November 28, 2017
  • EU OKs low-dose Xarelto to prevent recurrent VTE November 2, 2017
  • AstraZeneca touts Brilinta CV benefit with new analysis August 24, 2017
RSS Diabetes
  • Evotec and Novo Nordisk enter alliance for obesity, diabetes drug development August 23, 2018
  • New Diabetes Management Guidance: A Shift in Focus August 1, 2018
  • J&J seals deal on purchase of major diabetes devices firm June 14, 2018
  • Software That Uses Artificial Intelligence To Screen Eyes For Diabetes Damage Approved By FDA April 13, 2018
  • Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trials March 6, 2018
  • Boehringer strikes Jardiance outcomes deal with Prime PBM January 31, 2018
  • Lilly partners with Rimidi on digital diabetes management tool December 15, 2017
RSS Alzheimer’s
  • AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer’s With Immunotherapy July 25, 2018
  • AbbVie, Voyager set sights on ‘one-time’ Alzheimer’s treatment February 20, 2018
  • AbbVie, Alector to develop novel treatments for Alzheimer’s disease October 25, 2017
  • Assessing The Pipeline For Alzheimer’s Disease (Part I: Anti-Amyloid Antibodies) October 13, 2017
  • Biogen’s Alzheimer’s Hope Tops The Sector’s Most Valuable Pipeline Projects August 16, 2017
Create a website or blog at WordPress.com